Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Altmueller, Janine Dr.med. (29) Bunse, Mario Dr. (1) Harabula, Izabela-Cezara (1) Kammertöns, Thomas Dr. (5) Kieback, Elisa Dr. (1) Kopp, Joachim Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Lupianez Garcia, Dario Jesus Dr. (1) Pezzutto, Antonio Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (2) Willimsky, Gerald Dr. (5) (-) Blankenstein, Thomas Prof. Dr. (15) (-) Fischer, Cornelius Dr. (1) Bioinformatik der Genregulation (1) Experimentelle Ultrahochfeld-MR (5) Genetik metabolischer und reproduktiver Störungen (1) Genom-Editierung & Krankheitsmodelle (2) (-) Genomics (1) Immunregulation und Krebs (3) Magnetic Resonance (5) (-) Molekulare Immunologie und Gentherapie (15) Proteom Dynamik (1) RNA Biologie und Posttranscriptionale Regulation (1) Transgenics (2) Zelluläre Neurowissenschaften (2) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) (-) 2013 (11) 2014 (3) 2015 (4) (-) 2016 (5) 2017 (7) 2018 (6) 2019 (9) 2020 (3) 2021 (5) 2022 (11) 2023 (6) 2024 (2) 16 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Fischer, Cornelius Dr.GenomicsMolekulare Immunologie und Gentherapie 20132016 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Dezember 2013 / Canc Med IL-13 but not IL-4 signaling via IL-4Rα protects mice from papilloma formation during DMBA/TPA two-step skin carcinogenesis M. Rothe D. Quarcoo A.A. Chashchina S.V. Bozrova Z. Qin S.A. Nedospasov T. Blankenstein T. Kammertoens M.S. Drutskaya 17. Oktober 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein 15. Januar 2013 / Clin Cancer Res Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenes K. Anders T. Blankenstein 08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel 07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky 05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein 01. August 2013 / Nat Protoc Generation of transgenic mice with megabase-sized human yeast artificial chromosomes by yeast spheroplast-embryonic stem cell fusion L. Li T. Blankenstein 01. November 2013 / Nat Med High-throughput identification of antigen-specific TCRs by TCR gene capture C. Linnemann B. Heemskerk P. Kvistborg R.J.C. Kluin D.A. Bolotin X. Chen K. Bresser M. Nieuwland R. Schotte S. Michels R. Gomez-Eerland L. Jahn P. Hombrink N. Legrand C.J. Shu I.Z. Mamedov A. Velds C.U. Blank J.B.A.G. Haanen M.A. Turchaninova R.M. Kerkhoven H. Spits S.R. Hadrup M.H.M. Heemskerk T. Blankenstein D.M. Chudakov G.M. Bendle T.N.M. Schumacher 01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein 22. Juli 2016 / PLoS ONE Interleukin-7 modulates anti-tumor CD8+ T cell responses via its action on host cells K. Deiser D. Stoycheva U. Bank T. Blankenstein T. Schüler Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Dezember 2013 / Canc Med IL-13 but not IL-4 signaling via IL-4Rα protects mice from papilloma formation during DMBA/TPA two-step skin carcinogenesis M. Rothe D. Quarcoo A.A. Chashchina S.V. Bozrova Z. Qin S.A. Nedospasov T. Blankenstein T. Kammertoens M.S. Drutskaya
17. Oktober 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein
15. Januar 2013 / Clin Cancer Res Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenes K. Anders T. Blankenstein
08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky
05. Februar 2013 / Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein
01. August 2013 / Nat Protoc Generation of transgenic mice with megabase-sized human yeast artificial chromosomes by yeast spheroplast-embryonic stem cell fusion L. Li T. Blankenstein
01. November 2013 / Nat Med High-throughput identification of antigen-specific TCRs by TCR gene capture C. Linnemann B. Heemskerk P. Kvistborg R.J.C. Kluin D.A. Bolotin X. Chen K. Bresser M. Nieuwland R. Schotte S. Michels R. Gomez-Eerland L. Jahn P. Hombrink N. Legrand C.J. Shu I.Z. Mamedov A. Velds C.U. Blank J.B.A.G. Haanen M.A. Turchaninova R.M. Kerkhoven H. Spits S.R. Hadrup M.H.M. Heemskerk T. Blankenstein D.M. Chudakov G.M. Bendle T.N.M. Schumacher
01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
22. Juli 2016 / PLoS ONE Interleukin-7 modulates anti-tumor CD8+ T cell responses via its action on host cells K. Deiser D. Stoycheva U. Bank T. Blankenstein T. Schüler